SLC25A22 exerts oncogenic effects in colorectal cancer (Wong et al., 2016), gallbladder cancer (Du et al., 2019), and osteosarcoma cells (Chen and Wu, 2018), mainly through its transport of glutamate across the inner mitochondrial membrane to the mitochondrial matrix. The gene discussed is SLC25A22; the disease is colorectal cancer.